Skip to main content
Premium Trial:

Request an Annual Quote

Whitehead Biopsy-Standardization Study to Use Affy Chips

NEW YORK, Sept. 16 - The Whitehead Institute Center for Genome Research will use Affymetrix GeneChips in studies designed to standardize the collection and analysis of tumor-biopsy data, Affy said today.

 

Working with an undisclosed number of "clinical institutions," the Whitehead will "study sample collection from tissue biopsies, amplification, data collection, and analysis. ...," according to Affy.

 

The center believes that "standardization will ensure" that expression data will be "comparable" by scientists who currently use DNA chips in their cancer research.

 

It was not immediately clear when the study will begin, but Affy said data from the research will eventually be published.

 

Click here for more information.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.